AMSI invites the world to test and improve the revolutionary technology powering The COVID Hunter™.
The COVID Hunter™ utilizes a proprietary, non-invasive remote technique that is capable of accurate and quick detection of SARS-CoV-2 (Severe Acute Respiratory Syndrome-2) and its new mutants that cause COVID-19. The device is capable of detection of the virus inside the human body (people infected with SARS-CoV-2 (COVID-19 patients), and outside the human body on contaminated surfaces.
The device works by utilizing a combination of radiofrequency (RF) and infrared (IR) electromagnetic waves. Signals emitted from a tested medium are analyzed to detect a characteristic relaxation time for the chemically-stable molecule. The device and methodology work non-invasively for remotely detecting a marker of COVID-19 disease in a subject sample.
The device comprises of a transmitter that is configured to transmit IR to RF energy into a sample, a receiving circuitry that is configured to detect RF energy emitted from the sample in response to stimulation of the sample IR and RF energy, a signal processing circuitry that is configured to analyze the RF energy detected by the receiving circuitry to determine a resonant frequency, and a computer processor that is configured to identify the presence of a virus in the sample based on the determined resonant frequency.
Nobel Prize-winning molecular geneticist, Professor Mario Capecchi, serves as an advisor to AMSI on this and the company’s other breakthrough technologies - including a cure for allergic airway disease and chronic obstructive pulmonary disease (COPD) that is currently in the preliminary phase of FDA approval. AMSI technology builds upon research performed by Professor Maria Grant at the University of Florida and the University of Alabama at Birmingham and the work of Dr. Adeeb Al-Zoubi at Stem Cells Arabia in Jordan, the sister company of AMSI.